Fundz

Fundz Deep Dive

Everything you need to win BenevolentAI — in one platform.

Who to reach, what to say, and why now on BenevolentAI — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on BenevolentAI — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

BenevolentAI Reorganizes to Refocus on Serving Biopharma Industry Partners

Dec 11, 2024•over 1 year ago

Contract Type

partnership

United Kingdom

Description

BenevolentAI, an artificial intelligence biotech firm, has announced a reorganization to return to its original mission of serving biopharma industry partners. The changes include a refocus on core technologies for drug discovery and development.

Company Information

Company

BenevolentAI

Location

United Kingdom

About

The company has further backing from renowned UK entrepreneurs, including health tech success stories Tania Boler, CEO and Founder of Elvie; Dr. Jean Nehme, Co-Founder of Digital Surgery; and Sachin Dev Duggal, Founder of Builder.ai. “We draw on ancient wisdom and modern science, learning from the world’s leading experts, to guide people with the knowledge, skills, and tools to mitigate stress,” says the company in the press release.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for BenevolentAI's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.